Patent · US Active

Anti-angiogenic methods and compositions

US7893022B2 · kind B2 · utility

23Cited by

54References

17Claims

0Family size

Assignee

Sangamo Biosciences, Inc. · US

Inventors

H. Steve Zhang · Richmond, US
Philip D. Gregory · Richmond, US
Edward J. Rebar · Richmond, US

Key dates

Filing date	Oct 31, 2007
Grant date	Feb 22, 2011
Priority date	—
Expiry date	Mar 2, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2799/028
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are methods and compositions for treatment of conditions requiring inhibition of angiogenesis. Such conditions include those characterized by neovascularization, such as retinopathies, macular degeneration and various malignancies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.